Pingzhen, Taiwan

Yu-Chin Tseng

This inventor holds 1 USPTO granted patent. Top assignee: Institute of Nuclear Energy Research. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu-Chin Tseng. Retrieved from https://idiyas.com/inventor/yu-chin-tseng-lfo6k7em

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yu-Chin Tseng in Radiochemical Testing

Introduction

Yu-Chin Tseng is a notable inventor based in Pingjhen, Taiwan. He has made significant contributions to the field of radiochemistry, particularly in the testing of radiochemical purity. His work is essential for ensuring the quality and safety of radiopharmaceuticals used in medical applications.

Latest Patents

Yu-Chin Tseng holds a patent for a novel method titled "Method for testing radiochemical purity of Tc-99m-TRODAT-1." This invention utilizes high-performance liquid chromatography on a widely available C-18 column to effectively test the radiochemical purity of Tc-99m-TRODAT-1. This method enhances the reliability of radiochemical assessments, which is crucial for medical diagnostics.

Career Highlights

Tseng is affiliated with the Atomic Energy Council - Institute of Nuclear Energy Research, where he applies his expertise in nuclear energy and radiochemistry. His work has been instrumental in advancing the methodologies used in the testing of radiopharmaceuticals.

Collaborations

Some of his notable coworkers include Yuen-Han Yeh and Mei-Chih Wu. Their collaborative efforts contribute to the ongoing research and development in the field of nuclear energy and radiochemistry.

Conclusion

Yu-Chin Tseng's innovative approach to testing radiochemical purity represents a significant advancement in the field of radiochemistry. His contributions are vital for the safety and efficacy of medical applications involving radiopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…